Thermedical
CompanyUnited States
Thermedical develops one asset, in phase 3 (Saline Enhanced Radiofrequency (SERF) Ablation System in ventricular tachycardia). Mostly device; based in the United States.
- 1
- Asset
- Furthest stage
- Phase 3
- 0
- Trials
- 0
- Signals
Pipeline
1Saline Enhanced Radiofrequency (SERF) Ablation System
Saline enhanced radiofrequency catheter ablation system delivering thermal ablation to myocardial tissue
Phase 3, Device, ventricular tachycardia
Full company profiles: pipeline, trials, funding and people.